Correlation between Clinical Characteristics and Chest Computed Tomography Findings of Pulmonary Cryptococcosis

Table 3

Comparison of clinical characteristics between nodule or mass without GGA/consolidation type and inclusive GGA or consolidation type.

Clinical characteristics	Nodule or mass without GGA/consolidation type	Inclusive GGA or consolidation type	value
Number of patients	7 (100.0%)	9 (100.0%)
Male	5 (71.4%)	5 (55.5%)	0.633
Age (years), median [range]	73 [25–82]	60 [56–79]	0.873
≥70 years	4 (57.1%)	4 (44.4%)	>0.999
Host status
Immunocompromised	5 (71.4%)	8 (88.9%)	0.550
BMI, kg/m^2, median [range]	19.6 [16.0–24.0]	22.1 [17.6–25.0]	0.153
<18.5 kg/m^2	2 (28.6%)	1 (11.1%)	0.550
Symptoms
None	3 (42.9%)	3 (33.3%)	>0.999
HbA1c (%), median [range]	5.8 [5.1–6.5]	5.5 [4.9–7.0]	0.943
WBC (/μL), median [range]	7400 [6400–12300]	8100 [1500–31400]	0.427
Lym (/μL), median [range]	1300 [600–2900]	600 [230–2200]	0.265
<1000/μL	2 (28.6%)	5 (55.6%)	0.358
Hb (g/dL), median [range]	12.0 [8.9–16.5]	8.4 [4.4–14.9]	0.044
<10.0 mg/dL	1 (14.3%)	6 (66.7%)	0.060
Plt (×10^4/μL), median [range]	24.6 [10.2–36.0]	8.4 [1.4–30.3]	0.023
<10.0 × 10^4/μL	0 (0%)	5 (55.6%)	0.034
Albumin (g/dL), median [range]	3.3 [2.5–4.9]	2.9 [2.4–3.9]	0.184
<3.0 g/dL	1 (14.3%)	5 (55.6%)	0.145
ESR (mm/hr), median [range]	10 [1–62]	74 [10–78]	0.176
CRP (mg/dL), median [range]	0.5 [0.1–7.0]	1.4 [0.1–6.7]	0.310
≥1.0 mg/dL	1 (14.3%)	6 (66.7%)	0.060
IgG (mg/dL), median [range]	885 [467–2507]	983 [410–4121]	0.897
<800 mg/dL	3 (42.9%)	3 (37.5%)	>0.999

GGA: ground-glass attenuation; BMI: body mass index; HbA1c: hemoglobin A1c; WBC: white blood cell; Lym: lymphocyte cell; Hb: hemoglobin; Plt: platelet; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; and IgG: immunoglobulin G.